Philip A. Carpino

2.0k citations

42 papers · 1.1k indexed · h-index 20

Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity 8
Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis 5
Toxicology top 5%
Pharmacology top 5%
- Cannabis and Cannabinoid Research 5
Endocrinology, Diabetes and Metabolism top 10%
- Diabetes Treatment and Management 5
Molecular Biology
- Chemical Synthesis and Analysis 6
- Receptor Mechanisms and Signaling 4
Cellular and Molecular Neuroscience
- Neurotransmitter Receptor Influence on Behavior 5
Nutrition and Dietetics
- Biochemical Analysis and Sensing Techniques 4

Co-authors: E. J. Corey Andreas Spaltenstein Paul B. Hopkins Bryan Goodwin David A. Griffith V. Margaret Jackson Jean‐Philippe Fortin Roger B. Ruggeri
Cited by: Endocrine and Autonomic Systems Organic Chemistry Toxicology
Journals: Journal of the American Chemical Society (1 paper)Circulation (1 paper)Biochemistry (2 papers)
Partner nations: United States United Kingdom

In The Last Decade

Philip A. Carpino

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by Philip A. Carpino

Since Specialization

Citations

This map shows the geographic impact of Philip A. Carpino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Carpino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Carpino more than expected).

Fields of papers citing papers by Philip A. Carpino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Carpino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Carpino. The network helps show where Philip A. Carpino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip A. Carpino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip A. Carpino Line = papers co-authored together Philip A. Carpino links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy The American Journal of Cardiology ·Martin S. Maron,Hassan Rastegar,Noreen Dolan,Philip A. Carpino,Benjamin Koethe,Barry J. Maron,Ethan J. Rowin	2021	19
2	Development of a selective activity-based probe for glycosylated LIPA Bioorganic & Medicinal Chemistry Letters ·Adam G. Schwaid,Wanida Ruangsiriluk,Allan R. Reyes,Shawn Cabral,Francis Rajamohan,Meihua Tu,Jessica Ward,Philip A. Carpino	2016	3
3	Practical synthesis of capromorelin, a growth hormone secretagogue, via a crystallization-induced dynamic resolution Bioorganic & Medicinal Chemistry ·Colin R. Rose,Michael P. Zawistoski,Bruce A. Lefker,F. Michael Mangano,Ann S. Wright,Philip A. Carpino	2016	4
4	A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation Cell chemical biology ·Donna N. Petersen,Julie A. Hawkins,Wanida Ruangsiriluk,Kimberly A. Stevens,Bruce A. Maguire,Thomas N. O’Connell,Benjamin N. Rocke,Markus Boehm,Roger B. Ruggeri,Tim Rolph,David Hepworth,Paula M. Loria,Philip A. Carpino	2016	68
5	Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies Expert Opinion on Investigational Drugs ·V. Margaret Jackson,David A. Price,Philip A. Carpino	2014	20
6	A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification Nature Chemical Biology ·Whitney M. Nolte,Jean‐Philippe Fortin,Benjamin D. Stevens,Gary E. Aspnes,David A. Griffith,Lise R. Hoth,Roger B. Ruggeri,Alan M. Mathiowetz,Chris Limberakis,David Hepworth,Philip A. Carpino	2014	66
7	Mechanistic Characterization of a 2-Thioxanthine Myeloperoxidase Inhibitor and Selectivity Assessment Utilizing Click Chemistry–Activity-Based Protein Profiling Biochemistry ·Jessica Ward,Samantha N. Spath,Brandon Pabst,Philip A. Carpino,Roger B. Ruggeri,Gang Xing,Anna E Speers,Benjamin F. Cravatt,Kay Ahn	2013	27
8	Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries Bioorganic & Medicinal Chemistry Letters ·Allyn T. Londregan,David W. Piotrowski,Kentaro Futatsugi,Joseph S. Warmus,Markus Boehm,Philip A. Carpino,Janice E. Chin,Ann M. Janssen,Nicole Roush,Joanne Buxton,Terri Hinchey	2013	20
9	Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor Bioorganic & Medicinal Chemistry Letters ·Michael Fichtner,Eun-Sun Lee,Elizabeth Tomlinson,Dennis O. Scott,Peter Cornelius,Terrell A. Patterson,Philip A. Carpino	2012	6
10	Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·David A. Griffith,Diane M. Hargrove,Tristan S. Maurer,Charles A. Blum,Stéphane De Lombaert,John Inthavongsay,Lee E. Klade,Christine M. Mack,Colin R. Rose,Martin Sanders,Philip A. Carpino	2011	21
11	Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature Expert Opinion on Therapeutic Patents ·Philip A. Carpino,Bryan Goodwin	2010	40
12	Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist BMC Pharmacology ·John R. Hadcock,Philip A. Carpino,Philip A. Iredale,Robert L. Dow,Denise Gautreau,Lucinda Thiede,Dawn Kelly-Sullivan,Jeffrey S. Lizano,Xingrong Liu,Jeffrey Van Deusen,Karen Ward,Rebecca E. O’Connor,Shawn C. Black,David A. Griffith,Dennis O. Scott	2010	12
13	Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles Bioorganic & Medicinal Chemistry Letters ·Robert L. Dow,John R. Hadcock,Dennis O. Scott,Steven R. Schneider,Ernest S. Paight,Philip A. Iredale,Philip A. Carpino,David A. Griffith,Marlys Hammond,Paul DaSilva‐Jardine	2009	11
14	Revascularization Options for Ischemic Cardiomyopathy: On-Pump and Off-Pump Coronary Artery Bypass Surgery Cardiology ·Kamal R. Khabbaz,David DeNofrio,Marwan Kazimi,Philip A. Carpino	2004	0
15	Recent developments in ghrelin receptor (GHS-R1a) agonists and antagonists Expert Opinion on Therapeutic Patents ·Philip A. Carpino	2002	17
16	Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue Endocrine ·Lydia C. Pan,Philip A. Carpino,Bruce A. Lefker,Agnieszka R. Ragan,Steven M. Toler,John C. Pettersen,David O. Nettleton,Oicheng Ng,C.M. Pirie,Kristin L. Chidsey-Frink,Bihong Lu,David F. Nickerson,David A. Tess,Michelle Mullins,David B. MacLean,Paul DaSilva‐Jardine,David D. Thompson	2001	33
17	Outcome after combined carotid endarterectomy and coronary artery bypass is related to patient selection Journal of Vascular Surgery ·James M. Estes,Kamal R. Khabbaz,Marcos F. Barnatan,Philip A. Carpino,William C. Mackey	2001	13
18	A conformationally restrained series of AT1-selective angiotensin II antagonists Bioorganic & Medicinal Chemistry Letters ·Philip A. Carpino,Scott Sneddon,Jardine Paul da Silva,Magnus-Ayritey George T.,Rauch Albert L.,Burkard Michael R.	1994	6
19	Enantiospecific total synthesis of pseudopterosins A and E Journal of the American Chemical Society ·E. J. Corey,Philip A. Carpino	1989	77
20	A stereocontrolled synthesis of trans-alkene isosteres of dipeptides Tetrahedron Letters ·Andreas Spaltenstein,Philip A. Carpino,Fumio Miyake,Paul B. Hopkins	1986	14

About Philip A. Carpino

Philip A. Carpino is a scholar working on Endocrine and Autonomic Systems, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Regulation of Appetite and Obesity (8 papers), Chemical Synthesis and Analysis (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Carbohydrate Chemistry and Synthesis (5 papers), Cannabis and Cannabinoid Research (5 papers), Diabetes Treatment and Management (5 papers), Receptor Mechanisms and Signaling (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (90 citations), Organic Chemistry (365 citations) and Toxicology (39 citations). Philip A. Carpino has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include E. J. Corey, Andreas Spaltenstein, Paul B. Hopkins, Bryan Goodwin, David A. Griffith, V. Margaret Jackson, Jean‐Philippe Fortin, Roger B. Ruggeri, Dennis O. Scott and Robert L. Dow. Their work appears in journals such as Journal of the American Chemical Society, Circulation and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact